Chern Ein Oon

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Ashwaq Hamid Salem Yehya · 2 shared papers, 2021–2023 · strength 0.46
   • Paper Polymolecular botanical drug of Orthosiphon stamineus extract (C5OSEW5050ESA) as a complementary therapy to overcome ge… DOI 10.1016/j.jtcme.2022.10.002↗
   • Paper Complementary effects of Orthosiphon stamineus standardized ethanolic extract and rosmarinic acid in combination with g… DOI 10.1016/j.bj.2020.05.015↗
2. Pingping Hu · 1 shared paper, 2026 · strength 0.29
   • Paper Ellagic Acid Enhances RSL3-Induced Ferroptosis by Inhibiting the Nrf2/HO-1 Signaling Pathway in Pancreatic Ductal Adeno… DOI 10.1096/fj.202602231r↗
3. Jianhua Bai · 1 shared paper, 2026 · strength 0.29
   • Paper Ellagic Acid Enhances RSL3-Induced Ferroptosis by Inhibiting the Nrf2/HO-1 Signaling Pathway in Pancreatic Ductal Adeno… DOI 10.1096/fj.202602231r↗
4. Yun Jin · 1 shared paper, 2026 · strength 0.29
   • Paper Ellagic Acid Enhances RSL3-Induced Ferroptosis by Inhibiting the Nrf2/HO-1 Signaling Pathway in Pancreatic Ductal Adeno… DOI 10.1096/fj.202602231r↗
5. Carina Strell · 1 shared paper, 2015 · strength 0.06
   • Paper SIRT1 inhibition in pancreatic cancer models: contrasting effects in vitro and in vivo. DOI 10.1016/j.ejphar.2015.03.064↗
6. Arne Östman · 1 shared paper, 2015 · strength 0.06
   • Paper SIRT1 inhibition in pancreatic cancer models: contrasting effects in vitro and in vivo. DOI 10.1016/j.ejphar.2015.03.064↗
7. Jai Prakash · 1 shared paper, 2015 · strength 0.06
   • Paper SIRT1 inhibition in pancreatic cancer models: contrasting effects in vitro and in vivo. DOI 10.1016/j.ejphar.2015.03.064↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.